Resources

Details of OGTR monitoring and compliance activities during the quarter ended 31 December 2017.

These guidelines contain the requirements and conditions for certification of a Physical Containment Level 2 (PC2) Large Scale Facility issued pursuant to section 90 of the Gene Technology Act 2000 (the Act).

Checklist for annual inspection against the usual Conditions of Certification of the Gene Technology Regulator’s Guidelines for Certification of a Physical Containment Level 2 Large Scale Facility

Checklist against the requirements of the Gene Technology Regulator’s Guidelines for Certification of a Physical Containment Level 2 Large Scale Facility.

This document provides baseline information about the parent organism for use in risk assessments of genetically modified S. secundatum that may be released into the Australian environment.

People and organisations wishing to work with Genetically Modified Organisms (GMOs) have been able to do so provided they follow laws designed to protect people and the environment.

This issue focuses on preparing for a monitoring inspection.

The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the OGTR during 2016-17.

This survey was conducted in 2017. It explores the awareness, attitudes and understanding of general science and technology, and specific biotechnology issues.

Details of OGTR monitoring and compliance activities during the quarter ended 30 September 2017.

Details of OGTR monitoring and compliance activities during the quarter ended 30 June 2017.

This first issue focuses on Notifiable Low Risks Dealings (NLRDs).

Details of petunias that have been notified as genetically modified in Australia.

Details of the holders of a licence for dealings with GM petunias.

An report on the potential risks from inadvertent dealings with petunia genetically modified for altered flower colour.

Details of OGTR monitoring and compliance activities during the quarter ended 31 March 2017.

The report describes the roles and responsibilities of the Gene Technology Regulator (Regulator) and the OGTR. It provides a picture of the OGTR’s performance over the past 12 months.

This is a hypothetical case study provided as an example. It should not be cited as evidence in an application. Although the data and discussions are representative, this example may not include all  considerations needed when assessing risks from a proposed GM plant commercial release.

This protocol outlines the broad framework used by the Monitoring and Compliance Section when undertaking risk assessments. It also informs any risk management plans.

This protocol describes the review system used to assess operational and compliance issues that arise during monitoring, auditing and investigation of dealings with genetically modified organisms.

This document sets out the policy framework the Office of the Gene Technology Regulator (OGTR) will use when dealing with possible contraventions of the legislation in accordance with criminal, civil and administrative provisions.

Audit Protocol In accordance with the Gene Technology Act 2000

There has been a drop in both awareness and support for gene technologies in Australia since 2012, with mean levels of support dropping from 6.07 out of ten to 5.33. As in previous studies it appears that people with less knowledge of gene technology are less likely to support it.

This note describes a number of field monitoring procedures that provide an accurate basis upon which to determine
compliance or non-compliance in relation to field trials conducted under Dealings involving Intentional Release (DIRs).